Elvitegravir (Vitekta) is an oral HIV antiretroviral (ARV) medication; however, it's no longer available as a tablet on its own because it was discontinued.
| Common Brands | Vitekta |
|---|---|
| Drug Class | HIV ARV |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Discontinued |
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.
Find expert answers to your health questions so you can make the best decisions for yourself and your family.Health conditions
Medications & treatment
Access & affordability
Medication discounts
Vitekta is an HIV ARV integrase inhibitor. It prevents HIV from inserting itself into your DNA. This way, the virus can't grow and spread in your body.
Gilead, the manufacturer, stopped making Vitekta tablets in 2017. They chose to stop making the stand-alone tablet since most people take HIV ARV combination tablets. Their decision had nothing to do with safety of the medication.
